© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Panbela Therapeutics, Inc. (PBLA) stock remained unchanged at $0.35 a share on NASDAQ. The stock opened at $0.35, fluctuating between $0.35 to $0.35 during the session.
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Employees | 7 |
Beta | 0.94 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Panbela Therapeutics, Inc. (NASDAQ: PBLA) stock price is $0.35 in the last trading session. During the trading session, PBLA stock reached the peak price of $0.35 while $0.35 was the lowest point it dropped to. The percentage change in PBLA stock occurred in the recent session was 0% while the dollar amount for the price change in PBLA stock was -.
The NASDAQ listed PBLA is part of Biotechnology industry that operates in the broader Healthcare sector. Panbela Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Elizabeth Bruckheimer Ph.D.
Vice President & Chief Scientific Officer
Ms. Susan Horvath
Vice President of Fin., Chief Financial Officer, Sec. & Treasurer
Dr. Jennifer K. Simpson C.R.N.P., CRNP, M.S.N., Ph.D.
Chief Executive Officer, Pres & Director
Ms. Tammy Groene
Vice President of Operations
PBLA's closing price is 16.67% higher than its 52-week low of $0.30 where as its distance from 52-week high of $1.50 is -76.67%.
Number of PBLA employees currently stands at 7.
Official Website of PBLA is: https://www.panbela.com
PBLA could be contacted at phone 952 479 1196 and can also be accessed through its website. PBLA operates from 712 Vista Boulevard, Waconia, MN 55387, United States.
PBLA stock volume for the day was 262 shares. The average number of PBLA shares traded daily for last 3 months was 16.98K.
The market value of PBLA currently stands at $1.70M with its latest stock price at $0.35 and 4.85M of its shares outstanding.